Current Projects

Current Projects

REACHnet collaborates with partners locally and nationwide on patient-centered research. Here are a few of our current projects.

Adaptable: The Aspirin Study

Adaptable: The Aspirin Study

ADAPTABLE is a clinical trial comparing the effectiveness of 81mg versus 325mg daily doses of aspirin to prevent heart attacks and strokes in individuals living with heart disease. Participating REACHnet sites are Ochsner Health System and Baylor Scott & White Health.

ADAPTABLE is a clinical trial comparing the effectiveness of 81mg versus 325mg daily doses of aspirin to prevent heart attacks and strokes in individuals living with heart disease. Participating REACHnet sites are Ochsner Health System and Baylor Scott & White Health.

Learn More
LEAD Study: Louisiana Experiment Assessing Diabetes Outcomes

LEAD Study: Louisiana Experiment Assessing Diabetes Outcomes

The LEAD Study is a prospective observational study examining the impacts of Medicare reimbursement for non-face-to-face chronic care management services on health outcomes among patients with diabetes. Tulane University is leading this project in collaboration with REACHnet partner health systems and payer organizations in Louisiana.

The LEAD Study is a prospective observational study examining the impacts of Medicare reimbursement for non-face-to-face chronic care management services on health outcomes among patients with diabetes. Tulane University is leading this project in collaboration with REACHnet partner health systems and payer organizations in Louisiana.

Learn More
Health in Our Hands

Health in Our Hands

REACHnet is piloting the PTAS in six clinical sites. Patients are given tablets at the point of care during their routine clinical visits. They are given information about HiOH and given the opportunity to consent into the network. To see projects HiOH members have been invited to, click here.

REACHnet is piloting the PTAS in six clinical sites. Patients are given tablets at the point of care during their routine clinical visits. They are given information about HiOH and given the opportunity to consent into the network. To see projects HiOH members have been invited to, click here.

Learn More

WeighSmart

REACHnet will run its first clinical trial utilizing tablets, the PTAS and HiOH. Eligible patients will be approached at the point of care during routine clinical visits. If eligible, patients in the HiOH network will also receive information about participating in the trial. Both groups will be given an informational

REACHnet will run its first clinical trial utilizing tablets, the PTAS and HiOH. Eligible patients will be approached at the point of care during routine clinical visits. If eligible, patients in the HiOH network will also receive information about participating in the trial. Both groups will be given an informational video on the study and given the opportunity to consent. All enrolled participants will receive a special scale, which will wirelessly track weight.

Learn More